03 Dec

STUFF.CO.NZ _ Overseas medical researchers eye up NZ for clinical trials

Overseas medical researchers eye up NZ for clinical trials.

For that reason, New Zealand is always a consideration but more recently the country’s effective management of Covid-19 meant that the country was an obvious choice for the new study that was in planning prior to Covid-19.''

Jacquie Palmer, managing director of Pharmaceutical Solutions speaks to Stuff about New Zealand being the ideal destination for clinical trials.

Other News

The Benefits of Rapid Start Up and How to Achieve It

Time is often always a factor in the development of new therapies, especially for conditions with unmet medical needs or during global health emergencies like we saw with the pandemic.

Read more
PharmaSols CRO Dedicated Study Start-Up Team – Taking Trial Sites From Selection to Initiation Faster

Meet Jorrit Sipkema – Director Study Start-up at PharmaSols CRO, a HiRO company. Jorrit has worked over 20 years in clinical research in AsiaPac and Europe for Pharmaceutical companies, CRO's and Central Laboratories. His experience includes clinical operations, project management and quality assurance both at management and operations levels.

Read more
Clinical Trials in ANZ: Harnessing Population Diversity for Recruitment

Recruitment and retention of trial participants can often be a critical bottleneck in clinical research. It is widely accepted that almost half of all delays in clinical trials are a result of problems with patient recruitment and retention. When it comes to the success of clinical trials, patient recruitment and retention plays a pivotal role.

Read more